Clinical Trials Browser

Lymphoma, Non-Hodgkin, Motor Activity, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07485504 2026-03-20

Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies

Phase 1 Not yet recruiting

15 enrolled

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT07456189 2026-03-06

The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating

Phase NA Not yet recruiting

20 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07137481 2026-03-04

Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies

Phase 2 Not yet recruiting

70 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07297160 2026-03-04

CALySSEY

Phase 1 Not yet recruiting

88 enrolled

GenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Kidney Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT07441967 2026-03-02

The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation

Phase 2 Not yet recruiting

44 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07440290 2026-02-27

DETERMINE

Phase 2/3 Not yet recruiting

30 enrolled

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT06897137 2026-02-24

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Not yet recruiting

3,000 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07424833 2026-02-20

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Phase 1 Not yet recruiting

180 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT07403812 2026-02-11

Assessing DCog Short for Neurotoxicity in CAR-T

Phase NA Not yet recruiting

40 enrolled

Other hematologic neoplasm

Hematologic Neoplasms, Neurotoxicity Syndromes

NCT07367997 2026-01-26

CARE-RT

Phase NA Not yet recruiting

100 enrolled

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

NCT07362602 2026-01-23

Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies

Phase EARLY_PHASE1 Not yet recruiting

47 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07362732 2026-01-23

Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection

Phase EARLY_PHASE1 Not yet recruiting

20 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07358195 2026-01-22

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

Phase EARLY_PHASE1 Not yet recruiting

3 enrolled

Other hematologic neoplasm

Hematologic Neoplasms, Renal Insufficiency, Chronic

Clinical Trials

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

RENEW-IN

TITLE CLL

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies

The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating

Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies

CALySSEY

The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation

DETERMINE

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Assessing DCog Short for Neurotoxicity in CAR-T

CARE-RT

Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies

Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation